,,ii ,calendar ,no4 #cah #aahth ,,congress #b;d ,session ,s4 #fdd ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #b1 #bjbc,mr4 ,markey 7for himself1 ,mr4 ,paul1 ,mr4 ,sanders1 ,mr4 ,braun1 ,mr4 ,booker1 ,ms4 ,hassan1 ,mr4 ,lujn1 ,mr4 ,welch1 ,mr4 ,lee1 ,ms4 ,warren1 ,mr4 ,casey1 and ,mr4 ,heinrich7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,february #a1 #bjbd,reported by ,mr4 ,sanders1 with an amendment,strike out all after the enacting clause and insert the part printed in italic ,a ,,bill ,to expand the take-home prescribing of methadone through pharmacies4 #a4 ,short title ,this ,act may be cited as the ,modernizing ,opioid ,treatment ,access ,act4 #b4 ,expansion of methadone for opioid use disorder through prescribing and pharmacies 7a7 ,registration2 other care by telehealth 7#a7 ,definitions ,in this subsection3 7,a7 ,controlled substance2 detoxification treatment2 dispense2 maintenance treatment2 opioid ,the terms controlled substance1 detoxification treatment1 dispense1 maintenance treatment1 and opioid have the meanings given the terms in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb74 7,b7 ,secretary ,the term ,secretary means the ,secretary of ,health and ,human ,services4 7#b7 ,waiver 7,a7 ,in general ,the requirements of section #cjc7;h7 of ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;h77 applicable to methadone medication for opioid use disorder are waived1 and the ,attorney ,general1 in consultation with the ,secretary1 shall register persons described in subparagraph 7,b7 to prescribe methadone for opioid use disorder to be dispensed through a pharmacy for individuals for unsupervised use4 7,b7 ,persons described ,persons described in this subparagraph are persons who-- 7i7 are licensed1 registered1 or otherwise permitted1 by the ,united ,states or the jurisdiction in which they practice1 to prescribe controlled substances in the course of professional practice2 and 7ii7 are-- 7,i7 employees or contractors of an opioid treatment program2 or 7,,ii7 addiction medicine physicians or addiction psychiatrists who hold a subspecialty board certification in addiction medicine from the ,american ,board of ,preventive ,medicine1 a board certification in addiction medicine from the ,american ,board of ,addiction ,medicine1 a subspecialty board certification in addiction psychiatry from the ,american ,board of ,psychiatry and ,neurology1 or a subspecialty board certification in addiction medicine from the ,american ,osteopathic ,association4 7,c7 ,requirements for prescribing methadone ,the prescribing of methadone pursuant to subparagraph 7,a7 shall be-- 7i7 exclusively by electronic prescribing and dispensed to the patient treated pursuant to subparagraph 7,a72 7ii7 for a supply of not more than #cj days pursuant to each prescription2 and 7iii7 subject to the restrictions listed in section #h4ab7;i77#c7 of title #db1 ,code of ,federal ,regulations1 or successor regulation or guidance4 7,d7 ,requirements for dispensing methadone ,the dispensing of methadone to an individual pursuant to subparagraph 7,a7 shall be in addition to the other care that the individual continues to have access to through an opioid treatment program4 7,e7 ,registration requirements ,persons registered in a ,state pursuant to subparagraph 7,a7 shall-- 7i7 ensure and document1 with respect to each patient treated pursuant to subparagraph 7,a71 informed consent to treatment2 and 7ii7 include in such informed consent1 specific informed consent regarding differences in confidentiality protections applicable when dispensing through an opioid treatment program versus dispensing through a pharmacy pursuant to subparagraph 7,a74 7,f7 ,cessation and withdrawal of registration ,at the request of a ,state1 the ,attorney ,general1 in consultation with the ,secretary1 shall-- 7i7 cease registering persons in the ,state pursuant to subparagraph 7,a72 and 7ii7 withdraw any such registration in effect for a person in the ,state4 7,g7 ,maintenance and detoxification treatment ,maintenance treatment or detoxification treatment provided pursuant to subparagraph 7,a7 and other care provided in conjunction with such treatment1 such as counseling and other ancillary services1 may be provided by means of telehealth1 as determined jointly by the ,state and the ,secretary to be feasible and appropriate4 7b7 ,annual reporting ,not later than #ahj days after the date of enactment of this ,act1 and annually thereafter1 the ,assistant ,secretary for ,mental ,health and ,substance ,use and the ,administrator of the ,drug ,enforcement ,administration shall jointly submit a report to ,congress that includes-- 7#a7 the number of persons registered pursuant to subsection 7a72 7#b7 the number of patients being prescribed methadone pursuant to subsection 7a72 and 7#c7 a list of the ,states in which persons are registered pursuant to such subsection 7a74 #c4 ,sense of ,congress on need to reduce barriers to patient care through opioid treatment programs ,it is the sense of ,congress that-- 7#a7 patients receiving services through opioid treatment programs face barriers to their care2 and 7#b7 each ,state should align the regulation of opioid treatment programs in a manner that is consistent with the intent of this ,act4 #a4 ,short title ,this ,act may be cited as the ,modernizing ,opioid ,treatment ,access ,act4 #b4 ,expansion of methadone for opioid use disorder through prescribing and pharmacies ,section #cjc7;h7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;h771 is amended-- 7#a7 in paragraph 7#a7-- 7,a7 in the matter preceding subparagraph 7,a71 in the first sentence1 by inserting 7other than narcotic drugs in schedule ,,iii1 ,,iv1 or ,v7 after drugs2 and 7,b7 by striking subparagraph 7,b7 and inserting the following3 7,b7 if the ,attorney ,general determines that the applicant will comply with standards established by the ,attorney ,general respecting-- 7i7 security of stocks of narcotic drugs for such treatment2 and 7ii7 the maintenance of records 7in accordance with section #cjg7 on such drugs2 and 2 and 7#b7 by striking paragraph 7#b7 and inserting the following3 7#b7 7,a7 ,the requirements of paragraph 7#a7 applicable to methadone medication for opioid use disorder are waived1 and the ,attorney ,general1 in consultation with the ,secretary1 shall separately register persons described in subparagraph 7,b7 to prescribe methadone for opioid use disorder to be dispensed through a pharmacy for individuals for unsupervised use4 7,b7 ,persons described in this subparagraph are persons who-- 7i7 are licensed1 registered1 or otherwise permitted1 by the ,united ,states or the jurisdiction in which they practice1 to prescribe controlled substances in the course of professional practice2 and 7ii7 are addiction medicine physicians or addiction psychiatrists who hold a subspecialty board certification in addiction medicine from the ,american ,board of ,preventive ,medicine1 a board certification in addiction medicine from the ,american ,board of ,addiction ,medicine1 a subspecialty board certification in addiction psychiatry from the ,american ,board of ,psychiatry and ,neurology1 or a subspecialty board certification in addiction medicine from the ,american ,osteopathic ,association4 7,c7 ,the prescribing of methadone pursuant to subparagraph 7,a7 shall be-- 7i7 exclusively by electronic prescribing and dispensed to the patient treated pursuant to subparagraph 7,a72 7ii7 for a supply of not more than #cj days pursuant to each prescription2 and 7iii7 subject to the restrictions listed in section #h4ab7;i77#c7 of title #db1 ,code of ,federal ,regulations1 or successor regulation or guidance4 7,d7 ,the dispensing of methadone to an individual pursuant to subparagraph 7,a7 shall be in addition to the other care that the individual continues to have access to through an opioid treatment program4 7,e7 ,persons registered pursuant to subparagraph 7,a7 shall-- 7i7 ensure and document1 with respect to each patient treated pursuant to subparagraph 7,a71 informed consent to treatment2 and 7ii7 include in such informed consent1 specific informed consent regarding differences in confidentiality protections applicable when dispensing through an opioid treatment program versus dispensing through a pharmacy pursuant to subparagraph 7,a74 7,f7 ,at the request of a ,state1 the ,attorney ,general shall-- 7i7 cease registering persons in the ,state pursuant to subparagraph 7,a72 and 7ii7 withdraw any such registration in effect for a person in the ,state4 7,g7 ,maintenance treatment or detoxification treatment provided pursuant to subparagraph 7,a7 and other care provided in conjunction with such treatment1 such as counseling and other ancillary services1 may be provided by means of telehealth4 7#c7 ,not later than #ahj days after the date of enactment of this paragraph1 and annually thereafter1 the ,assistant ,secretary for ,mental ,health and ,substance ,use and the ,administrator of the ,drug ,enforcement ,administration shall jointly submit to ,congress a report that includes-- 7,a7 the number of persons registered pursuant to paragraph 7#b72 7,b7 a list of ,states in which persons are registered pursuant to paragraph 7#b74 4 ,february #a1 #bjbd,reported with an amendment